Ground Swell Capital’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,136
Closed -$11.4K 197
2024
Q4
$11.4K Buy
+1,136
New +$14.3K 0.02% 133

Other funds holding IMUX

Ground Swell Capital's IMUX Position: Q1 2025 in Review

Ground Swell Capital sold out of Immunic (IMUX) in Q1 2025, closing a stake of 1,136 shares — an estimated $11.4K sold.

Ground Swell Capital first reported a position in IMUX in Q4 2024 and held it in 1 quarter. The position peaked at $11.4K in Q4 2024. 64 funds tracked by Wall St. Rank hold IMUX as of Q1 2025.

  • Ground Swell Capital reported no remaining Immunic position as of Q1 2025 after selling out during the quarter.
  • Ground Swell Capital sold 1,136 Immunic shares in Q1 2025, an estimated $11.4K.
  • Ground Swell Capital first reported a position in Immunic in Q4 2024 and held it in 1 quarter.
  • Ground Swell Capital's Immunic position peaked at $11.4K in Q4 2024.
  • 64 funds tracked by Wall St. Rank held Immunic as of Q1 2025.

Based on Ground Swell Capital's 13F filing for Q1 2025, filed 13 May 2025.